Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-24
    E.g., 2018-06-24

Articles

Pages

35281 items
12:19 PM, Jun 22, 2018  |  BC Week In Review | Company News  |  Deals

AHA, ADA partner with industry to launch diabetes, cardiovascular disease initiative

The American Heart Association and American Diabetes Association partnered with Boehringer Ingelheim GmbH (Ingelheim, Germany), Eli Lilly and Co. (NYSE:LLY) and Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) to launch a 3.5 year initiative to help...
12:15 PM, Jun 22, 2018  |  BC Week In Review | Company News  |  Deals

UCSD launches bacteriophage treatment center

The University of California San Diego launched the Center for Innovative Phage Applications and Therapeutics (IPATH) to develop bacteriophages to fight multidrug-resistant bacteria. The initial focus will be on treating chronic infections associated with cystic...
12:14 PM, Jun 22, 2018  |  BC Week In Review | Company News  |  Deals

J&J opens JLABS incubator in NYC

The Johnson & Johnson Innovation LLC subsidiary of Johnson & Johnson (NYSE:JNJ) opened JLABS@NYC, a JLABS incubator in New York City, with 26 resident companies. Resident companies at JLABS include the four winners of the JLABS@NYC...
11:09 AM, Jun 22, 2018  |  BC Week In Review | Company News  |  Deals

Roche snaps up rest of Foundation to enhance global access

Roche (SIX:ROG; OTCQX:RHHBY) is acquiring the remaining shares of cancer diagnostics company Foundation Medicine Inc. (NASDAQ:FMI) that it does not already own for $137 per share in cash, or $2.4 billion. In 2015, Roche had acquired...
8:35 AM, Jun 22, 2018  |  BC Week In Review | Company News  |  Deals

BridgeBio launches mitochondrial-focused subsidiary

BridgeBio Pharma LLC (Palo Alto, Calif.) launched Fortify Therapeutics Inc. June 18 with $20 million and an exclusive license to compounds from NeuroVive Pharmaceutical AB (SSE:NVP; OTCQX:NEVPF) to treat Leber’s hereditary optic neuropathy. Fortify will develop...
12:59 PM, Jun 15, 2018  |  BC Week In Review | Company News  |  Deals

Broad, Editas in research funding deal

Editas Medicine Inc. (NASDAQ:EDIT) and the Broad Institute of MIT and Harvard entered into a sponsored research agreement in which the gene editing company will provide funding for the institute to "conduct research useful or...
12:58 PM, Jun 15, 2018  |  BC Week In Review | Company News  |  Deals

Wuxi to use Insilico's AI platform to speed drug discovery

WuXi AppTec Co. Ltd. (Shanghai:603259) led a venture round for Insilico Medicine Inc. (Baltimore, Md.) and partnered with the artificial intelligence company to discover and develop new molecules. Insilico CEO Alex Zhavoronkov told BioCentury it raised...
12:57 PM, Jun 15, 2018  |  BC Week In Review | Company News  |  Deals

Syncona backs pair of gene therapy start-ups

Syncona Ltd. (LSE:SYNC) launched SwanBio Therapeutics Ltd. (Boston, Mass.) and Orbit Biomedical Ltd. (Philadelphia, Pa.), a pair of gene therapy newcos for CNS and retinal disorders, respectively. The U.K. investment firm provided $23 million of SwanBio's...
12:57 PM, Jun 15, 2018  |  BC Week In Review | Company News  |  Deals

Shionogi gains Asian rights to SAGE-217

Shionogi & Co. Ltd. (Tokyo:4507) licensed exclusive rights to SAGE-217 from Sage Therapeutics Inc. (NASDAQ:SAGE) in Japan, Taiwan and South Korea to treat major depressive disorder (MDD). Shionogi will pay Sage $90 million up front, with...
12:32 PM, Jun 15, 2018  |  BC Week In Review | Company News  |  Deals

Sanofi, Translate in mRNA vaccines deal

Translate Bio Inc. (Lexington, Mass.) partnered with the Sanofi Pasteur division of Sanofi (Euronext:SAN; NYSE:SNY) to develop mRNA vaccines against up to five undisclosed pathogens for infectious diseases. Translate is to receive $45 million up front...

Pages